Ftse Mib
33.573,41
-0,40%
DAX
18.155,24
-0,04%
S&P 500
5.463,81
-0,10%
NASDAQ
17.747,66
0,17%
Bitcoin
60.939,70
-1,42%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Medivation (MDV) Medivation (MDV) Notizie

MDV

Medivation (MDV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MDV
DataOraFonteTitoloSimboloCompagnia
20/03/200713:30PR Newswire (US)Medivation Common Stock Begins Trading on Nasdaq Global Market Under the Symbol 'MDVN'NYSE:MDV
19/03/200714:00PR Newswire (US)Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's DiseAMEX:MDVMedivation
15/03/200717:01Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating In Update Coverage By Dutton AssociatesAMEX:MDVMedivation
08/03/200722:00PR Newswire (US)Medivation Common Stock Approved for Listing on the Nasdaq Global MarketAMEX:MDVMedivation
05/03/200714:00PR Newswire (US)Medivation to Present at Cowen and Company's 27th Annual Healthcare ConferenceAMEX:MDVMedivation
26/02/200714:00PR Newswire (US)Medivation's MDV3100 Shown to Be Effective in a Preclinical Model of Hormone-Refractory Prostate CancerAMEX:MDVMedivation
16/02/200714:00PR Newswire (US)Preclinical Efficacy Data on Medivation's MDV3100 to Be Presented at ASCO-sponsored Prostate Cancer SymposiumAMEX:MDVMedivation
05/02/200714:00PR Newswire (US)Medivation to Present at BIO CEO & Investor Conference 2007AMEX:MDVMedivation
30/01/200714:00PR Newswire (US)Medivation's Dimebon(TM) Phase 2 Trial Results to be Presented at 8th International Conference on Alzheimer's and Parkinson's DiAMEX:MDVMedivation
17/01/200714:00PR Newswire (US)Medivation Names Lisa Taylor Vice President of Commercial DevelopmentAMEX:MDVMedivation
06/12/200618:00Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating in Update Coverage by Dutton AssociatesAMEX:MDVMedivation
05/12/200614:00PR Newswire (US)Medivation Appoints Sue Wollowitz, Ph.D., Vice President of Chemistry and ManufacturingAMEX:MDVMedivation
04/12/200620:25PR Newswire (US)Medivation, Inc. Adopts Shareholder Rights PlanAMEX:MDVMedivation
15/11/200614:30PR Newswire (US)Medivation Provides Clinical Development Update for Its Three ProgramsAMEX:MDVMedivation
08/11/200622:00PR Newswire (US)Medivation to Host Conference Call on November 15 to Provide Clinical Development Update for Lead Product Candidate Dimebon(TM)AMEX:MDVMedivation
01/11/200614:00PR Newswire (US)Medivation Announces Participation in Rodman & Renshaw 8th Annual Healthcare ConferenceAMEX:MDVMedivation
19/10/200615:00PR Newswire (US)Medivation Begins Phase 1-2a Trial of Dimebon(TM) in Huntington's DiseaseAMEX:MDVMedivation
16/10/200615:00PR Newswire (US)Medivation to Present Additional Alzheimer's Disease Data at BIO Investor Forum 2006AMEX:MDVMedivation
28/09/200610:00Business WireMedivation Receives FDA Permission to Begin Dimebon Huntington's Disease TrialAMEX:MDVMedivation
21/09/200613:00Business WireMedivation's Dimebon Meets All Five Efficacy Endpoints in Phase 2 Alzheimer's Disease Study; Conference Call Begins at 1:00 P.M.AMEX:MDVMedivation
14/09/200622:05Business WireMedivation Appoints Dr. Andrew A. Protter Vice President of Preclinical DevelopmentAMEX:MDVMedivation
23/08/200618:00Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating In Update Coverage By Dutton AssociateAMEX:MDVMedivation
17/07/200610:00Business WireTony Vernon Joins Medivation's Board of DirectorsAMEX:MDVMedivation
15/06/200618:23PR Newswire (US)Emerging Growth Equities, Ltd. Initiates Coverage of Medivation, Inc. (Amex: MDV) With a BUY RatingNYSE:MDV
23/05/200610:00Business WireMedivation to Present at the Dutton Associates' ``Recognizing Opportunity'' Health Sciences Small Cap ConferenceAMEX:MDVMedivation
16/05/200622:38Business WireMedivation Announces $14.25 Million Registered Direct OfferingAMEX:MDVMedivation
10/05/200622:07Business WireMedivation Provides Update on Huntington's Disease INDAMEX:MDVMedivation
08/05/200622:05Business WireMedivation to Present at the Rodman & Renshaw 3rd Annual Global Healthcare ConferenceAMEX:MDVMedivation
04/05/200618:00Business WireDutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating in Initiating Coverage by Dutton AssocAMEX:MDVMedivation
15/03/200616:35PR Newswire (US)American Stock Exchange Lists Common Stock Of Medivation IncorporatedNYSE:MDV
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MDV

La tua Cronologia

COIN
LIMEBTC
iMe Lab
TG
SAA1
J Safra Sarasin Fund Man...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network